AYURVEDIC MANAGEMENT OF ANEMIA (IRON DEFICIENCY ANEMIA)IN CHILDREN

RANDOMIZED CONTROLLED CLINICAL TRIAL ON EFFECTIVENESS OF SANGFER LIQUID IN THE MANAGEMENT OF PANDU (IRON DEFICIENCY ANAEMIA) IN CHILDREN (10-16 YEARS) _______________________________________________________________________

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/09/045157

Enrollment

Registered

2022-09-01

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E638- Other specified nutritional deficiencies

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children aged 10 to 16 years presenting with lakshanas of pandu, and positive results for investigatory parameters of pandu roga (iron deficiency anemia) whose parents willing to give consent to participate them in the study 2.Children with Hb% between 8-11 gm % 3.Microcytic hypochromic anemia 4.Serum ferritin level 5.After obtaining written informed consent from parents, children of both gender with hemoglobin level below normal range and PBS showing microcytosis and hypochromia will be included.

Exclusion criteria

Exclusion criteria: 1.Those with Hb% below 8 gm% 2.Those suffering from leukaemia, bleeding disorders, tuberculosis, renal and other nutritional deficiencies etc will be excluded 3.Any other type of anemia except IDA 4.IDA with any associated severe complication

Design outcomes

Primary

Measure	Time frame
Registered Patient Under Trial Group(A)will be given Ayurvedic Intervention and Standard control Group(B)will be given Non Ayurvedic Intervention Primary outcomes shall be observing of possible decrease in the symptoms scores and objective parameters associated with IDA in both the Groups after 3 months of InterventionTimepoint: Group A Ayurvedic Intervention Group A Ayurvedic Intervention Sangfer liquid 10 ml BD for 3 months orally Group B Standard control Non Ayurvedic Intervention Tab Ferrous ascorbate 50 mg BD for 3 months orally Assessment will be done After completion of treatment and follow up assessment will be done after 1 month	—

Measure

Time frame

Registered Patient Under Trial Group(A)will be given Ayurvedic Intervention and Standard control Group(B)will be given Non Ayurvedic Intervention Primary outcomes shall be observing of possible decrease in the symptoms scores and objective parameters associated with IDA in both the Groups after 3 months of InterventionTimepoint: Group A Ayurvedic Intervention Group A Ayurvedic Intervention Sangfer liquid 10 ml BD for 3 months orally Group B Standard control Non Ayurvedic Intervention Tab Ferrous ascorbate 50 mg BD for 3 months orally Assessment will be done After completion of treatment and follow up assessment will be done after 1 month

—

Secondary

Measure	Time frame
Changes in the blood parameters and improvement in general health status. Timepoint: sangfer liquid 10ml BD for 3 months orally follow up assessment will be done after 1 month	—

Countries

India

Contacts

Public ContactDr Nataraj H R

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Tanniruhalla Hassan

drnatarajhr@sdmcahhassan.org8310022925

Outcome results